Cytosorbents Files 8‑K Furnishing Investor Presentation under Reg FD

What Happened
Cytosorbents Corporation (CTSO) filed a Form 8‑K on August 7, 2026, furnishing an investor presentation pursuant to Regulation FD (Item 7.01). The presentation is attached as Exhibit 99.1 and is incorporated by reference. The filing also includes the Interactive XBRL cover page (Exhibit 104) under Item 9.01.

Key Details

• Filing date: August 7, 2026; SEC accession no. 0001104659-26-092691.
• Item reported: 7.01 (Regulation FD Disclosure) — investor presentation furnished as Exhibit 99.1.
• Item 9.01 lists exhibits, including Exhibit 99.1 (Investor Presentation) and Exhibit 104 (Inline XBRL cover page).
• The 8‑K furnishes the presentation to make information publicly available per Reg FD; it does not present audited financial statements in this filing.

Why It Matters
This filing makes the company’s latest investor presentation publicly available and ensures material information is disclosed in compliance with Regulation FD. Retail investors should review Exhibit 99.1 for the company’s current messaging on strategy, operations, or outlook and watch for any related press releases or subsequent SEC filings (e.g., earnings (Item 2.02) or executive changes) for financial details or actionable items.